Pervasive transcriptome interactions of protein-targeted drugs

Linglan Fang1, Willem A Velema1, Yujeong Lee1

  • 1Department of Chemistry, Stanford University, Stanford, CA, USA.

Nature Chemistry
|August 31, 2023
PubMed

Insights

Protein-targeted drugs can interact with the human transcriptome, causing unintended biological effects. This study introduces a new method to identify these RNA interactions, potentially improving drug safety and efficacy.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Genomics

Background:

  • Off-target drug toxicity leads to significant health and economic burdens.
  • While protein interactions are studied, intracellular RNA interactions as off-targets remain under-explored.
  • Understanding RNA interactions is crucial for assessing drug safety and efficacy.

Purpose of the Study:

  • To develop and apply a novel reactivity-based RNA profiling method.
  • To investigate in vivo transcriptome interactions of FDA-approved small-molecule drugs.
  • To assess the potential of RNA off-target binding to contribute to drug toxicity.

Main Methods:

  • Development of a reactivity-based RNA profiling methodology.
  • In vivo application of the method to study drug-transcriptome interactions.
  • Analysis of RNA loci associated with protein binding and structural changes.

Main Results:

  • Protein-targeted drugs extensively interact with the human transcriptome.
  • These interactions can lead to unintended biological effects on RNA functions.
  • Off-target binding frequently occurs at RNA sites involved in protein interactions and structural modifications.

Conclusions:

  • Drugs approved for protein targets can pervasively interact with RNA.
  • Characterizing drug-transcriptome interactions can reveal potential toxicity mechanisms.
  • Assessing RNA interactions may enhance drug specificity and prevent clinical failures.

Related Concept Videos

Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
195
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.4K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
583
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
191